论文部分内容阅读
为探讨卵巢癌合理的手术治疗方案，分析了８６例手术治疗的临床资料，将卵巢恶性肿瘤的手术范围和方式归纳为四类，并强调术后辅助腹腔化疗。术后随访满３年者３１例，满５年者１１例，其中Ⅰ～Ⅱ期３年生存率为８０％（８／１０），术后满５年的３例均存活；Ⅲ期３年生存率为５７．１％（１２／２１），５年生存率２５％（２／８）。作者认为（１）肿瘤细胞减灭术是治疗晚期卵巢癌的首选方法和主要手段，应尽可能地切除原发肿瘤及所能看到的盆腹腔内转移癌灶。但对个别病例要注意掌握适应证；（２）对早期病例应常规施行腹膜后淋巴［盆腔淋巴及（或）腹主动脉旁淋巴］清除；对晚期病例应在手术基本切除干净（残留癌灶≤２ｃｍ）的情况下，积极施行淋巴清除术，以提高生存率；（３）在细胞减灭术中，必须认真对待肠转移癌的处理。
In order to explore a reasonable surgical treatment of ovarian cancer, 86 cases of surgical treatment of clinical data were analyzed, the scope and methods of surgical treatment of ovarian cancer were grouped into four categories, and emphasis on postoperative adjuvant intraperitoneal chemotherapy. After 3 years of follow-up, 31 patients were followed up for 5 years. The 3-year survival rate was 80% (8/10) in stage Ⅰ-Ⅱ and 3 cases Survival rate was 57.1% (12 of 21), 5-year survival rate of 25% (2/8). The authors believe that (1) tumor cytoreductive surgery is the preferred method of treatment of advanced ovarian cancer and the main means should be possible to remove the primary tumor and can see the pelvic metastasis foci. But for individual cases should pay attention to indications; (2) routine cases of early retroperitoneal lymph node [pelvic lymph node and / or para-aortic lymph node] clearance; for advanced cases of surgery should be basically removed (residual cancer ≤ 2cm), actively perform lymphadenectomy in order to improve the survival rate; (3) cytoreductive surgery, we must take seriously the treatment of intestinal cancer.